2 June 2022

Ankylosing Spondylitis Biologics

Biologics improve psoriasis but not CV risk

28 April 2022

Biologics Pain

Kicking the opioid-first prescribing habit

28 April 2022

Biologics PBS

Regulatory review – March 2022 PBAC recommendations

21 April 2022

Biologics Diet Exercise Juvenile Arthritis Osteoporosis TGA

NSAIDs blunt clodronate effect on preventing fractures

21 April 2022

Biologics COVID-19 Global Health

Covid-19 Global Rheumatology Alliance registry set to close

7 April 2022

Biologics COVID-19

Bad news for the usual suspects

17 March 2022

Ankylosing Spondylitis Biologics Pharmacy Guild of Australia

Mavrilimumab opens up GCA promise

17 March 2022

Biologics COVID-19 Reactive Arthritis

A silver lining to sulfasalazine’s covid fear

3 March 2022

Anti JAKS Biologics COVID-19 Fibromyalgia

Antipyretics ‘reduce covid immunity, help fight TB’

3 March 2022

Biologics COVID-19

Rheumatology patients share their experiences of the covid pandemic

24 February 2022

Ankylosing Spondylitis Biologics Polymyalgia Rheumatica Rheumatoid Arthritis Spondyloarthritis

Why men won’t take allopurinol

24 February 2022

Biologics

Regulatory review – November 2021 PBAC recommendations

17 February 2022

Biologics osteomyelitis Spondyloarthritis

Rates and predictors of MTX side effects

17 February 2022

Biologics Pain Rheumatoid Arthritis

In knee OA, opioid benefits aren’t worth the cost

17 February 2022

Biologics PBS

Naloxone trial ‘saves three Australians a day’

17 February 2022

Biologics Pain

Long-term paracetamol may boost CV risk